SCHEDULE 13G/A: Investment Funds Disclose 9.9% Stake in PAVMED INC. via Common Stock and Convertible Notes
Beneficial Ownership Report
Ayrton Capital LLC, Alto Opportunity Master Fund, SPC Segregated Master Portfolio B, and Waqas Khatri have disclosed a combined 9.9% beneficial ownership stake in PAVMED INC., comprising common stock and convertible notes.
Summary
- Ayrton Capital LLC, Alto Opportunity Master Fund, SPC Segregated Master Portfolio B, and Waqas Khatri (collectively, the "Reporting Persons") have reported beneficial ownership of 1,226,316 shares of PAVMED INC. Common Stock.
- This ownership represents 9.9% of the Issuer's Common Stock class.
- The stake is composed of 29,816 shares of Common Stock directly held and 1,196,500 shares issuable upon the conversion of certain convertible notes.
- The shares issuable from convertible notes are subject to a 9.99% beneficial ownership blocker.
- The percentage of class is calculated based on 11,068,566 shares of Common Stock outstanding as of November 11, 2024, as stated in PAVMED INC.'s Form 10-Q filed on November 14, 2024.
- The reported holdings are as of December 31, 2024.
Sentiment
Score: 5
Explanation: Neutral. This is a standard disclosure of a significant passive ownership stake, providing factual information without indicating positive or negative operational performance or future prospects for the issuer.
Positives
- The disclosure of a significant 9.9% stake by institutional investors (Ayrton Capital LLC and Alto Opportunity Master Fund) and an individual (Waqas Khatri) can be perceived as a vote of confidence in PAVMED INC.
Future Outlook
N/A
Industry Context
This filing is a disclosure of a significant ownership stake by specific investment entities and an individual in PAVMED INC. It does not provide broader industry trends or context.
Stakeholder Impact
- Shareholders: The disclosure of a significant institutional and individual stake may provide some level of confidence or signal potential future interest in the company's stock, although the filing indicates a passive investment.
Key Dates
| Date | Description |
|---|---|
| 11/11/2024 | Date as of which 11,068,566 shares of PAVMED INC. Common Stock were outstanding. |
| 11/14/2024 | Date PAVMED INC. filed its Form 10-Q, which provided the outstanding share count. |
| 12/31/2024 | Date of the event requiring the filing of this statement; date as of which the reported holdings are accurate. |
| 02/13/2025 | Signature date of the Schedule 13G filing. |
Keywords
PAVMED INC., Beneficial Ownership, Schedule 13G, Common Stock, Convertible Notes, Ayrton Capital LLC, Alto Opportunity Master Fund, Waqas Khatri, SEC Filing, Investment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.